Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) - Total Liabilities
Based on the latest financial reports, Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has total liabilities worth CN¥2.63 Billion CNY (≈ $384.61 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Total Liabilities Trend (2000–2025)
This chart illustrates how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Zhangzhou Pientzehuang Pharmaceutical Co's working capital to evaluate short-term liquidity relative to the company's equity base.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhangzhou Pientzehuang Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CSPC Pharmaceutical Group Limited
F:CVG
|
Germany | €12.15 Billion |
|
China Aerospace Times Electronics Co Ltd
SHG:600879
|
China | CN¥23.89 Billion |
|
Arrow Electronics Inc
NYSE:ARW
|
USA | $29.14 Billion |
|
Deutsche Lufthansa AG
XETRA:LHA
|
Germany | €38.30 Billion |
|
Vietnam JSCmmercial Bank for Industry and Trade
VN:CTG
|
Vietnam | ₫2588.06 Trillion |
|
Raytron Technology Co Ltd
SHG:688002
|
China | CN¥3.66 Billion |
|
WISE PLC SPONS.ADR/1
F:6WS0
|
Germany | €17.86 Billion |
|
Moog Inc
NYSE:MOG-A
|
USA | $2.80 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Zhangzhou Pientzehuang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 600436 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual total liabilities of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.47 Billion ≈ $361.73 Million |
-8.48% |
| 2024-12-31 | CN¥2.70 Billion ≈ $395.23 Million |
-14.53% |
| 2023-12-31 | CN¥3.16 Billion ≈ $462.40 Million |
+13.67% |
| 2022-12-31 | CN¥2.78 Billion ≈ $406.79 Million |
+17.86% |
| 2021-12-31 | CN¥2.36 Billion ≈ $345.14 Million |
+21.01% |
| 2020-12-31 | CN¥1.95 Billion ≈ $285.20 Million |
+5.86% |
| 2019-12-31 | CN¥1.84 Billion ≈ $269.40 Million |
+36.36% |
| 2018-12-31 | CN¥1.35 Billion ≈ $197.57 Million |
+10.39% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.97 Million |
-4.97% |
| 2016-12-31 | CN¥1.29 Billion ≈ $188.34 Million |
+71.24% |
| 2015-12-31 | CN¥751.60 Million ≈ $109.98 Million |
+13.48% |
| 2014-12-31 | CN¥662.34 Million ≈ $96.92 Million |
-0.71% |
| 2013-12-31 | CN¥667.05 Million ≈ $97.61 Million |
-1.21% |
| 2012-12-31 | CN¥675.22 Million ≈ $98.81 Million |
+77.83% |
| 2011-12-31 | CN¥379.69 Million ≈ $55.56 Million |
+4.61% |
| 2010-12-31 | CN¥362.97 Million ≈ $53.11 Million |
-15.07% |
| 2009-12-31 | CN¥427.35 Million ≈ $62.54 Million |
+34.20% |
| 2008-12-31 | CN¥318.45 Million ≈ $46.60 Million |
+50.19% |
| 2007-12-31 | CN¥212.03 Million ≈ $31.03 Million |
+93.59% |
| 2006-12-31 | CN¥109.53 Million ≈ $16.03 Million |
+28.01% |
| 2005-12-31 | CN¥85.56 Million ≈ $12.52 Million |
+334.47% |
| 2004-12-31 | CN¥19.69 Million ≈ $2.88 Million |
-52.44% |
| 2003-12-31 | CN¥41.40 Million ≈ $6.06 Million |
-75.79% |
| 2002-12-31 | CN¥170.99 Million ≈ $25.02 Million |
+37.51% |
| 2001-12-31 | CN¥124.34 Million ≈ $18.20 Million |
+5.98% |
| 2000-12-31 | CN¥117.33 Million ≈ $17.17 Million |
-- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals… Read more